intervention

3:40
Genetic abnormalities for detecting patients at risk of AML
Srdan Verstovsek
1:34
The importance of quickly spotting the signs of AML
Srdan Verstovsek
4:19
Intervening on time: how hypomethylating agents can prevent transition to AML
Srdan Verstovsek
1:30
Yoga as a non-pharmacological intervention for MPNs
Ruben Mesa
2:00
What are the non-drug-related aspects of patient care?
Claire Harrison
2:29
Fatigue after lymphoma treatment – overview of effective interventions
Marije van der Lee
6:47
AL amyloidosis and a critical, early diagnosis
Giampaolo Merlini
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJHemOnc is intended for healthcare professionals